118 related articles for article (PubMed ID: 31511183)
1. Something Is Better Than Nothing: The Value of Active Intervention in Stated Preferences for Treatments to Delay Onset of Alzheimer's Disease Symptoms.
Johnson FR; DiSantostefano RL; Yang JC; Reed SD; Streffer J; Levitan B
Value Health; 2019 Sep; 22(9):1063-1069. PubMed ID: 31511183
[TBL] [Abstract][Full Text] [Related]
2. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.
Johnson FR; Hauber B; Özdemir S; Siegel CA; Hass S; Sands BE
J Manag Care Pharm; 2010 Oct; 16(8):616-28. PubMed ID: 20866166
[TBL] [Abstract][Full Text] [Related]
3. Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers.
Morel T; Aymé S; Cassiman D; Simoens S; Morgan M; Vandebroek M
Orphanet J Rare Dis; 2016 May; 11(1):70. PubMed ID: 27225337
[TBL] [Abstract][Full Text] [Related]
4. Patient Preferences for Lung Cancer Interception Therapy.
Janssen EM; Smith IP; Liu X; Pierce A; Huang Q; Kalsekar I; Vachani A; Mansfield C
JAMA Netw Open; 2023 Nov; 6(11):e2342681. PubMed ID: 37948077
[TBL] [Abstract][Full Text] [Related]
5. The Patient Voice: Exploring Treatment Preferences in Participants with Mild Cognitive Concerns to Inform Regulatory Decision Making.
Mansfield C; Bullok K; Fuhs JV; Tockhorn-Heidenreich A; Andrews JS; DiBenedetti D; Matthews BR; Darling JC; Sutphin J; Hauber B
Patient; 2022 Sep; 15(5):551-564. PubMed ID: 35435572
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic preference for Alzheimer's disease treatments: a discrete choice experiment with caregivers and neurologists.
Dranitsaris G; Zhang Q; Mu L; Weyrer C; Drysdale E; Neumann P; Atri A; Monfared AAT
Alzheimers Res Ther; 2023 Mar; 15(1):60. PubMed ID: 36964606
[TBL] [Abstract][Full Text] [Related]
7. Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease.
Mühlbacher A; Johnson FR; Yang JC; Happich M; Belger M
Value Health; 2016 Jan; 19(1):66-74. PubMed ID: 26797238
[TBL] [Abstract][Full Text] [Related]
8. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
Gonzalez JM; Johnson FR; McAteer H; Posner J; Mughal F
Br J Dermatol; 2017 Mar; 176(3):777-785. PubMed ID: 27292093
[TBL] [Abstract][Full Text] [Related]
9. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
10. Determinants for acceptance of preventive treatment against heart disease - a web-based population survey.
Bo NJ; Ejg JD; Dorte GH; Lind BB; Veldt LP
BMC Public Health; 2014 Aug; 14():783. PubMed ID: 25086654
[TBL] [Abstract][Full Text] [Related]
11. Mobilising the Next Generation of Stated-Preference Studies: the Association of Access Device with Choice Behaviour and Data Quality.
Vass CM; Boeri M
Patient; 2021 Jan; 14(1):55-63. PubMed ID: 33355916
[TBL] [Abstract][Full Text] [Related]
12. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers.
Neumann PJ; Kuntz KM; Leon J; Araki SS; Hermann RC; Hsu MA; Weinstein MC
Med Care; 1999 Jan; 37(1):27-32. PubMed ID: 10413389
[TBL] [Abstract][Full Text] [Related]
13. Patient preferences for treatment of low back pain-a discrete choice experiment.
Kløjgaard ME; Manniche C; Pedersen LB; Bech M; Søgaard R
Value Health; 2014 Jun; 17(4):390-6. PubMed ID: 24968999
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease Patients' Willingness to Accept Medication Risk to Avoid Future Disease Relapse.
Bewtra M; Fairchild AO; Gilroy E; Leiman DA; Kerner C; Johnson FR; Lewis JD
Am J Gastroenterol; 2015 Dec; 110(12):1675-81. PubMed ID: 26482859
[TBL] [Abstract][Full Text] [Related]
15. Patient and parent preferences for immunoglobulin treatments: a conjoint analysis.
Mohamed AF; Kilambi V; Luo MP; Iyer RG; Li-McLeod JM
J Med Econ; 2012; 15(6):1183-91. PubMed ID: 22846048
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences for depression treatment programs and willingness to pay for treatment.
Morey E; Thacher JA; Craighead WE
J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
[TBL] [Abstract][Full Text] [Related]
17. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
[TBL] [Abstract][Full Text] [Related]
18. PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
Poulos C; Kinter E; van Beek J; Christensen K; Posner J
Int J Technol Assess Health Care; 2018 Jan; 34(4):425-433. PubMed ID: 30251947
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
